Toward a genetic analysis of tumor rejection antigens

Tum variants: immunogenic variants obtained by mutagen treatment of tumor cells.

Immunology today·2014

Noxp20 and Noxp70, two new markers of early neuronal differentiation, detected in teratocarcinoma-derived neuroectodermic precursor cells.

Journal of neurochemistry·2006

Identification of a MAGE-1 peptide recognized by cytolytic T lymphocytes on HLA-B*5701 tumors.

Tissue antigens·2004

New MAGE-4 antigenic peptide recognized by cytolytic T lymphocytes on HLA-A1 tumor cells.

Tissue antigens·2003

Immunisation of metastatic cancer patients with MAGE-3 protein combined with adjuvant SBAS-2: a clinical report.

European journal of cancer (Oxford, England : 1990)·2002

A MAGE-A4 peptide presented by HLA-B37 is recognized on human tumors by cytolytic T lymphocytes.

Tissue antigens·2002

Cancer immunotherapy with oncolytic myxoma virus.

Advances in cancer research·2026

Cancer terminator viruses: Unique conditionally replication competent oncolytic viruses producing therapeutic anti-cancer immunomodulating agents.

Advances in cancer research·2026

Advancing clinical translation of oncolytic adenoviruses.

Advances in cancer research·2026

Operation oncolysis: Reoviruses in the theater of cancer war.

Advances in cancer research·2026

AAV vectors for cancer gene therapy.

Advances in cancer research·2026

Vesicular stomatitis virus (VSV) as an oncolytic therapeutic agent for cancer.

Advances in cancer research·2026

Generation and characterization of an isogenic gene-corrected iPSC line CARIMi009-A-1 from a Hutchinson-Gilford Progeria Syndrome (HGPS) patient with a heterozygous G608G mutation in the LMNA gene.

Stem cell research·2026

A Rare De Novo Missense Mutation in IFT122 Confers a Genetic Susceptibility Factor of Idiopathic Pediatric Uveitis Via Trio-based Whole-Exome Sequencing.

Advanced science (Weinheim, Baden-Wurttemberg, Germany)·2026

Integrated Genomic and Proteomic Analysis Reveals T-B Lymphocyte Signatures in the MYCN Driven "Immune Desert" of Specific Neuroblastoma Subtypes.

CNS neuroscience & therapeutics·2026

Genetic Modifiers of Cardiac Remodeling Severity in IVS4+919G>A-Associated Fabry Cardiomyopathy.

International journal of molecular sciences·2026

Dissecting Missing Heritability in Rare Inherited Macular Dystrophies.

Genes·2026

Site-Resolved Plasma-Protein Architecture of Infection Susceptibility: A Cis-pQTL Mendelian Randomization and Colocalization Study.

Genes·2026

Related Experiment Videos

Toward a genetic analysis of tumor rejection antigens

Related Concept Videos

Tum variants: immunogenic variants obtained by mutagen treatment of tumor cells.

Noxp20 and Noxp70, two new markers of early neuronal differentiation, detected in teratocarcinoma-derived neuroectodermic precursor cells.

Identification of a MAGE-1 peptide recognized by cytolytic T lymphocytes on HLA-B*5701 tumors.

New MAGE-4 antigenic peptide recognized by cytolytic T lymphocytes on HLA-A1 tumor cells.

Immunisation of metastatic cancer patients with MAGE-3 protein combined with adjuvant SBAS-2: a clinical report.

A MAGE-A4 peptide presented by HLA-B37 is recognized on human tumors by cytolytic T lymphocytes.

Cancer immunotherapy with oncolytic myxoma virus.

Cancer terminator viruses: Unique conditionally replication competent oncolytic viruses producing therapeutic anti-cancer immunomodulating agents.

Advancing clinical translation of oncolytic adenoviruses.

Operation oncolysis: Reoviruses in the theater of cancer war.

AAV vectors for cancer gene therapy.

Vesicular stomatitis virus (VSV) as an oncolytic therapeutic agent for cancer.

Generation and characterization of an isogenic gene-corrected iPSC line CARIMi009-A-1 from a Hutchinson-Gilford Progeria Syndrome (HGPS) patient with a heterozygous G608G mutation in the LMNA gene.

A Rare De Novo Missense Mutation in IFT122 Confers a Genetic Susceptibility Factor of Idiopathic Pediatric Uveitis Via Trio-based Whole-Exome Sequencing.

Integrated Genomic and Proteomic Analysis Reveals T-B Lymphocyte Signatures in the MYCN Driven "Immune Desert" of Specific Neuroblastoma Subtypes.

Genetic Modifiers of Cardiac Remodeling Severity in IVS4+919G>A-Associated Fabry Cardiomyopathy.

Dissecting Missing Heritability in Rare Inherited Macular Dystrophies.

Site-Resolved Plasma-Protein Architecture of Infection Susceptibility: A Cis-pQTL Mendelian Randomization and Colocalization Study.

Related Experiment Videos

Toward a genetic analysis of tumor rejection antigens

Related Concept Videos

Related Articles